Peter Selin, an experienced business development executive, has been appointed chief business officer at Oasmia Pharmaceutical AB, a Swedish specialty pharma company. He was most recently head of business operations at Inceptua Group, a pharmaceutical services company, and before that, was head of corporate development at Swedish Orphan Biovitrum AB (Sobi).
Oasmia Pharmaceutical announced the appointment on 10 August 2020.
Copyright 2020 Evernow Publishing Ltd